Because AusSuper aren’t in the habit of running businesses and current management hasn’t given any indication they know how to successfully manage one either - a take private with current management would be a near impossible sell to their investment committee given their history of value destruction. They need an operator ala BGH who they’ve teamed up with on a couple of deals (Navitas etc) but they wouldn’t touch SYR so the AusSuper take private scenario would only work if there was a resource focussed financial sponsor who wanted a capital partner. And given how cheap SYR is any deep pocketed US resources fund would just buy it outright - having AusSuper there would just get in the way.
I just can’t see this scenario manifesting.
- Forums
- ASX - By Stock
- SYR
- Index issues
Index issues, page-26
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $325.9M |
Open | High | Low | Value | Volume |
32.0¢ | 32.5¢ | 31.3¢ | $327.5K | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 735736 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 122209 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 733456 | 0.310 |
36 | 1192146 | 0.305 |
57 | 2911968 | 0.300 |
14 | 1118584 | 0.295 |
17 | 3631667 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 159788 | 31 |
0.320 | 116385 | 12 |
0.325 | 203749 | 10 |
0.330 | 183743 | 9 |
0.335 | 216100 | 7 |
Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online